Medindia LOGIN REGISTER
Medindia
Advertisement

$50,000 Judgment Entered Against Defendant Amy Yueh, Pharma CI Conference Organizer in Superior Court of New Jersey

Thursday, September 17, 2009 General News
Advertisement


TEANECK, N.J., Sept. 10 After an 8 day trial, Amy Yueh, the organizer of the Pharma CI Conference was found on September 4, 2009 by the Superior Court of New Jersey to have engaged in tortious interference with prospective economic advantage and breaching her duty of loyalty.
Advertisement

In reaching the decision following the trial that ended in July 2009, Ellen Koblitz, Presiding Judge of the Superior Court of New Jersey, considered testimony provided by former SCIP (Society of Competitive Intelligence Professionals) Presidents Cliff Kalb and Martha Matteo. In its opinion, the Court entered judgment in favor of Apaporis, awarding $52,000 in damages.
Advertisement

Judge Ellen Koblitz also stated that Yueh "clearly took unfair advantage of her employer by misleading the 2008 (Pharma CI) conference participants into thinking that she had an agreement that she could continue the CI conference."

The Court also found that "knowing that (her employer) was out of the country and that she was ready to go public with the conference, she preempted Apaporis and unfairly undercut Apaporis' ability to compete on an equal basis in running the conference. She also took her three months of work on the 2008 Apaporis conference with her to run her own conference."

Amy Yueh revealed in court documents that the 2008 Pharma CI Conference had revenues of $417,145 and net profits of $285,156.

The lawsuit was filed in the Superior Court of New Jersey against Amy Yueh and her companies Acralinx Agenda and Amintell LLC.

CONTACT: Mark Alexay, +1-201-452-4023, [email protected]

SOURCE Apaporis
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close